Skip to content

Coronary Arteriogenetic Heparinized Exercise

Coronary ARteriogenesis With Combined Heparin and EXercise Therapy in Chronic Refractory Angina

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03350737
Acronym
CARHEXA
Enrollment
32
Registered
2017-11-22
Start date
2013-02-01
Completion date
2019-12-31
Last updated
2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stable Angina, Refractory Angina

Keywords

No-option patients

Brief summary

This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitation, while the other half will undergo only physical rehabilitation.

Detailed description

Our approach is based on the combination of pharmacological stimuli (with heparin) on top of a 2-week cycle of physical rehabilitation. The rationale for this chemical-physical cocktail stems from the fact that increase in shear stress (achieved with exercise), or heparin (when used alone) have no significant effect on coronary arteriogenesis. Nevertheless, when the two stimuli are coupled coronary arteriogenesis is consistently present, and clinically significant. The basic principle of heparin treatment is to potentiates angiogenic growth factors, which are over expressed by increased shear stress at the site of pre-existing collateral vessels as a result of exercise or pacing. Although the precise mechanisms by which heparin potentiates arteriogenesis remain to be completely elucidated, heparin administration combined with exercise has great potential in treating patients with effort angina who are not indicated for conventional revascularization therapy.

Interventions

Standard treadmill exercise session

DRUGHeparin

Heparin i.v.

OTHERPlacebo

Sodium Chloride 0.9% i.v.

Sponsors

Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy
CollaboratorOTHER_GOV
Clinical Centre of Serbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective, randomized, open-label study design. These no-option patients will be allocated (16 for each group) to 2 treatments

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with documented coronary artery disease not amenable of future treatment and belonging to no-option category with symptoms consistent with angina pectoris

Exclusion criteria

* Patients with unstable angina, recent myocardial infarction, uncontrolled hypertension, hemodynamically valvular heart disease, bronchial asthma, and neurologic and/or orthopedic illnesses that limit exercise capacity . * Patients receiving vitamin K antagonist. * Patients actively involved in programmes of cardiac rehabilitation or exercise training.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Canadian Cardiovascular Society (CCS) angina severity class at 2 weeks2 weeksCCS class ranging from 1 (mild) to 4 (severe) before and after the 2-week physical rehabilitation.

Secondary

MeasureTime frameDescription
Change from Baseline peak stress wall motion score index (WMSI) at 2 weeks2 weeksPeak WMSI at stress echocardiography before and after 2-week physical rehabilitation at . Wall motion score index is assessed by using 17- segment model of left ventricle (1=normal, 4=dyskinetic).
Change from baseline peak stress global longitudinal strain (GLS) at 2 weeks2 weeksPeak stress GLS assessed by echocardiography before and after the 2-week physical rehabilitation.

Other

MeasureTime frameDescription
Change from Baseline Coronary Collateral Circulation (CCC) at 2 weeks2 weeksCCC score assessed by multi dimensional computed tomography (CT) before and after 2-week physical rehabilitation. Distal filling of the epicardial segment is semiquantitatively classified by using a four-point scale according to patterns at coronary CT angiography (CTA) (0 = absence of distal filling; 1 = partial distal filling, with a length less than one-third of the segment; 2 = partial distal filling, with a length between one-third and two-thirds of the segment; 3 = complete or partial distal filling, with a length longer than two-thirds of the segment). A coronary CTA scores correspond fully to Rentrop classification (coronary CTA score of 0 or 1 to Rentrop 0 or 1, coronary CTA score of 2 or 3 to Rentrop 2 or 3). Coronary CTA score of 3 is indicative of well-developed collaterals, contrary to scores of 0-2 (poorly developed). Also we look for change in growth of baseline bridging antegrade collaterals at 2 weeks (0= not present, 1= present)
Change from Baseline Stable Angina questionnaire (SAQ) at 4 weeks2 weeks to one month19-item Seattle SAQ that assesses angina frequency, angina stability, physical limitations, treatment satisfaction, and disease perception/QoL

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026